Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers

por Lai, Li, Ghebremariam, Yohannes T.
Publicado 2016

Pharmacovigilance using Clinical Text

por LePendu, Paea, Iyer, Srinivasan V, Bauer-Mehren, Anna, Harpaz, Rave, Ghebremariam, Yohannes T, Cooke, John P, Shah, Nigam H
Publicado 2013

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

por Shah, Nigam H., LePendu, Paea, Bauer-Mehren, Anna, Ghebremariam, Yohannes T., Iyer, Srinivasan V., Marcus, Jake, Nead, Kevin T., Cooke, John P., Leeper, Nicholas J.
Publicado 2015

FXR Agonist INT-747 Upregulates DDAH Expression and Enhances Insulin Sensitivity in High-Salt Fed Dahl Rats

por Ghebremariam, Yohannes T., Yamada, Keisuke, Lee, Jerry C., Johnson, Christine L. C., Atzler, Dorothee, Anderssohn, Maike, Agrawal, Rani, Higgins, John P., Patterson, Andrew J., Böger, Rainer H., Cooke, John P
Publicado 2013

Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis

por Ghebremariam, Yohannes T, Cooke, John P, Gerhart, William, Griego, Carol, Brower, Jeremy B, Doyle-Eisele, Melanie, Moeller, Benjamin C, Zhou, Qingtao, Ho, Lawrence, de Andrade, Joao, Raghu, Ganesh, Peterson, Leif, Rivera, Andreana, Rosen, Glenn D
Publicado 2015